Building Your Custom Blood Panel: A Tiered Approach

The CBC is your hematological foundation. It measures red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. For enhanced athletes, the critical value is hematocrit — the percentage of your blood volume taken up by red blood cells. Compounds like EQ (boldenone), high-dose testosterone, and Anadrol can push hematocrit into dangerous territory above 54%, increasing blood viscosity and clotting risk. A CBC alone cannot tell you why hematocrit is rising or what to do about it — that needs the context that higher tiers provide.

The CMP is your metabolic dashboard. It includes creatinine and eGFR (kidney function), ALT and AST (liver/muscle stress), glucose, electrolytes, total protein, and bilirubin. For athletes, creatinine is almost always elevated due to muscle mass — this does not mean your kidneys are failing. But the CMP cannot distinguish muscle-derived ALT/AST from liver-derived ones, and creatinine-based eGFR systematically underestimates kidney function in muscular individuals. The CMP tells you something is changing, but it cannot tell you whether that change is training, pharmacology, or pathology.

Total cholesterol, HDL, LDL (calculated), and triglycerides. For enhanced athletes, this panel is borderline useless on its own — especially the calculated LDL. When HDL crashes (a known effect of most AAS), the Friedewald equation underestimates LDL by 10-30%. You need ApoB to know your true cardiovascular risk. The standard lipid panel at least gives you a direction: if triglycerides are high and HDL is low, your metabolic health is under pressure regardless of AAS use. But "direction" is not "precision," and precision is what you need for informed decision-making.

Unlike ALT and AST, which rise from both muscle and liver damage, GGT is liver-specific. It does not budge from training. A normal GGT with elevated AST/ALT confirms the elevation is muscle-derived — a critical distinction that prevents unnecessary cycle-interruption panic. An elevated GGT (above 45 U/L) with elevated AST/ALT means your liver is actually stressed. This single $8-12 marker is the most cost-effective way to resolve the most common false alarm in AAS blood work. According to the IFCC reference interval standards, GGT is the preferred marker for detecting hepatobiliary disease in physically active populations precisely because it is unaffected by muscle mass or training status.

Creatine Kinase is the single most powerful indicator of muscle stress. After a heavy leg workout, CK can spike to 2,000-10,000 U/L — levels that would send a non-athlete to the ER. Knowing your baseline CK (usually 100-250 U/L when fully rested) prevents false alarms and gives you context for every other muscle-derived marker. If your CK is elevated at draw time, you know to interpret AST and creatinine with caution. CK trends over time also reflect recovery status: consistently rising CK despite adequate rest indicates overtraining or insufficient recovery between sessions.

Ferritin reflects your body's iron stores. High-dose testosterone and certain AAS can increase ferritin over time, while frequent blood donations (common for hematocrit management) can deplete it dramatically. Low ferritin causes fatigue, poor recovery, cognitive fog, and hair loss — symptoms easily mistaken for "low T" or overtraining. The target range: 50-150 ng/mL. Below 30 ng/mL and you are functionally iron-deficient, even if your hemoglobin and RBC count look normal. Many athletes on frequent donation schedules find themselves in the 15-25 ng/mL range, wondering why they feel exhausted despite "optimal" hormone levels.

AAS use can suppress thyroid function, particularly with higher androgen loads. Low TSH and T4 contribute to fatigue, poor mood, and metabolic slowdown — symptoms that mimic low testosterone or high estrogen. TSH alone is not enough; free T4 tells you whether your thyroid is actually producing hormone or just being suppressed at the pituitary level. Optimal TSH for athletes: 0.5-2.5 mIU/L (the standard lab range of 0.5-5.0 is too broad for active individuals). Free T4 should be in the upper third of the reference range for optimal metabolic function.

Vitamin D is not optional — it is a steroid hormone that influences testosterone production, immune function, bone density, mood, and inflammation. Athletes who train indoors year-round are almost universally deficient or insufficient. The optimal range for enhanced athletes is 50-80 ng/mL. Below 30 ng/mL, you are leaving performance on the table and increasing injury risk. Supplementation is cheap (2,000-5,000 IU/day), but you need to test to know your baseline and adjust your dose accordingly.

Total testosterone without SHBG tells you almost nothing. SHBG (sex hormone-binding globulin) binds to testosterone and makes it biologically inactive. AAS suppress SHBG dramatically — sometimes down to 10-15 nmol/L from a normal of 30-50. Low SHBG means your total testosterone may look low even when free testosterone is adequate or high. Always test SHBG alongside total testosterone. If your SHBG is below 20 nmol/L on-cycle, that is expected pharmacology; if it stays low off-cycle, it signals metabolic issues that need attention. The calculated free testosterone (using total T, SHBG, and albumin) is the most clinically relevant metric for assessing your actual androgen exposure.

This is the most important addition in Tier 3. Creatinine-based eGFR overestimates kidney function in athletes because creatinine is produced by muscle. A muscular person can have an eGFR below 60 mL/min (classified as "stage 3" chronic kidney disease) with perfectly healthy kidneys. Cystatin C is not affected by muscle mass, so it gives you the real number. The difference between your creatinine-based eGFR and your Cystatin C-based eGFR tells you exactly how much your muscle mass is skewing the picture. Research published in the Clinical Journal of the American Society of Nephrology shows that Cystatin C-based eGFR is significantly more accurate than creatinine-based eGFR in individuals with above-average muscle mass. Every enhanced athlete should confirm kidney function with Cystatin C at least once to establish a true baseline.

LDL cholesterol is a proxy. ApoB is the actual measurement: it counts the number of atherogenic particles in your blood. Two people with the same LDL of 130 mg/dL can have very different ApoB levels — and very different cardiovascular risk. For enhanced athletes, ApoB is especially important because AAS can cause particle shifting (more small, dense LDL particles) that LDL cholesterol alone misses completely. The European Society of Cardiology recommends ApoB as a primary target for cardiovascular risk assessment, particularly in populations with metabolic disturbances. Target ApoB: below 90 mg/dL for enhanced athletes; below 80 mg/dL if you have other risk factors like family history of heart disease or elevated Lp(a). At roughly $25, ApoB is the highest-value marker in all of blood work.

Lipoprotein(a) is a genetically determined cardiovascular risk factor. Unlike LDL or ApoB, it does not change much with diet or lifestyle. But AAS can raise Lp(a) by 20-50% in some individuals, converting a moderate genetic risk into a significant one. Test it once — that is usually sufficient since it is primarily genetically determined. If your Lp(a) is below 30 nmol/L, you have one less thing to worry about. If it is above 125 nmol/L, you need aggressive ApoB management and more frequent cardiovascular monitoring. This marker is the reason some athletes develop cardiovascular issues at moderate AAS doses while others handle heavy cycles without problems — individual susceptibility varies enormously.

Standard estradiol assays are designed for women and overestimate estradiol in men at low levels — exactly where most men on AAS operate. Always request the sensitive (LC/MS) estradiol assay. Estradiol management is the difference between feeling great on-cycle and feeling terrible. Too low (below 10 pg/mL) and you get joint pain, low libido, brain fog, and cardiovascular risks from impaired HDL function. Too high (above 60-80 pg/mL) and you get anxiety, water retention, high blood pressure, and gyno risk. The sweet spot for most men on-cycle is 20-40 pg/mL, but individual optimal ranges vary — some men feel best at 15 pg/mL, others need 50 pg/mL.

Prolactin rises with 19-nor compounds (trenbolone, nandrolone, deca) and certain orals. Elevated prolactin causes sexual dysfunction (delayed ejaculation, low libido), mood destabilization, and breast tissue proliferation in extreme cases. IGF-1 tracks growth hormone activity — essential if you use GH or GH-secretagogues (GHRP-6, Ipamorelin, CJC-1295). HbA1c is your 3-month average glucose. Even if your fasting glucose is normal, HbA1c can reveal metabolic drift from GH use or insulin sensitivity changes on-cycle. Optimal HbA1c for athletes: below 5.2%. Above 5.6% on-cycle requires protocol adjustment — do not ignore it.

Fasting insulin tells you whether your pancreas is having to work overtime to keep glucose normal. High fasting insulin (above 15 uIU/mL) with normal glucose = insulin resistance. This is common with GH use and high-dose androgens. The HOMA-IR score (calculated from fasting glucose and insulin) is the earliest detectable marker of metabolic dysfunction — it catches problems months before HbA1c or fasting glucose show changes. Magnesium is essential for over 300 enzymatic reactions, including testosterone synthesis and glucose metabolism. RBC magnesium (intracellular) is more accurate than serum magnesium. Low magnesium amplifies muscle cramps, blood pressure issues, and poor sleep.

Homocysteine is an amino acid that, when elevated, damages blood vessels and increases clotting risk. It rises with high red meat intake, certain AAS (especially EQ, which interferes with vitamin B metabolism), and genetic variants (MTHFR). Optimal: below 8 umol/L. Above 12 umol/L signals increased cardiovascular and clotting risk. Simple B-vitamin supplementation (methylfolate 1 mg, methyl-B12 1 mg, B6 25 mg daily) usually brings it down within 4-8 weeks, but you need to test first to know if it is elevated. Test homocysteine at least once — if it is normal, you can retest annually or when you start EQ.

Free T3 is the active thyroid hormone. Your TSH and free T4 can look normal while free T3 is low — a pattern called "low T3 syndrome" that causes fatigue, poor recovery, and metabolic slowdown. AAS can suppress T4-to-T3 conversion. DHT (dihydrotestosterone) drives hair loss, prostate growth, and androgenic effects. On DHT-derived compounds (masteron, anavar, primobolan, Winstrol), DHT levels can be supraphysiological. Monitoring DHT contextualizes androgenic side effects and helps you decide whether 5-alpha reductase inhibitors (finasteride, dutasteride) are appropriate.

These adrenal markers reflect how your stress-response system is handling the physiological burden of training and AAS. DHEA-S is an androgen precursor that often crashes on-cycle because exogenous androgens suppress the HPA axis. Cortisol can be elevated from training stress, AAS use, or sleep disruption. A high cortisol-to-DHEA-S ratio is a hallmark of overtraining and HPA axis dysfunction. Testing these markers helps distinguish "I need a deload week" from "I need to fix my protocol." Post-cycle, low DHEA-S and low cortisol indicate incomplete HPA recovery and explain persistent fatigue and low libido.

PTH (parathyroid hormone) reflects calcium metabolism and can rise with vitamin D deficiency or kidney stress. LDH (lactate dehydrogenase) is a broad marker of cell turnover that rises with tissue damage, training, and certain compounds — useful for detecting hemolysis when combined with potassium and AST. Uric acid rises with high-protein diets, AAS use, and kidney stress. Elevated uric acid increases gout risk and cardiovascular inflammation. In one analysis of GearCheck user data, uric acid was elevated in roughly 30% of athletes on high-dose cycles, particularly those with high red meat intake and dehydration.

ApoA1 is the main protein in HDL and tracks reverse cholesterol transport — your body's ability to clear plaque. A low ApoA1 confirms HDL dysfunction beyond just a low HDL number. LDL-P (LDL particle count) directly measures the number of LDL particles, which can be high even when LDL-C looks normal. GlycA is a novel marker of systemic inflammation that predicts cardiovascular risk independently of CRP. sTfR (soluble transferrin receptor) distinguishes true iron deficiency from inflammation-induced low ferritin — invaluable for athletes who donate blood frequently and have chronically low ferritin.

The Lipoprotein Insulin Resistance score uses your lipid profile to estimate insulin resistance. It is cheaper and more stable than a glucose tolerance test and predicts metabolic dysfunction earlier than fasting glucose. On-cycle insulin resistance is common but often invisible in standard panels. The Lp-IR score gives you a number to track over time. Score below 40 is optimal; above 60 signals developing insulin resistance that needs attention through diet adjustment, increased cardio, or protocol modification.

On-cycle with orals: ALT, AST, GGT, creatinine, eGFR, hematocrit, hemoglobin, potassium — these can change within days of starting a new compound or adjusting dose. If you use orals, test at 4 weeks to catch liver stress before it accumulates. If you start a high-dose injectable cycle, test at 4-6 weeks.

Full lipid panel, ApoB, Cystatin C, fasting glucose, fasting insulin, TSH, free T4, testosterone, free testosterone (calculated), SHBG, estradiol, prolactin, ferritin, vitamin D. These markers reflect medium-term trends and respond to protocol changes over weeks rather than days. Quarterly testing catches metabolic drift, accumulating cardiovascular stress, and thyroid suppression before they become problems. This is the most important testing interval for most athletes — it provides enough data points to establish trends without excessive cost.

HbA1c, Lp(a), homocysteine, DHEA-S, cortisol, magnesium, uric acid. These change slowly and do not require frequent monitoring unless you have specific concerns. Bi-annual testing ensures you catch gradual shifts without wasting money on markers that will not show meaningful change in 90 days.

DHT, IGF-1, PTH, ApoA1, LDL-P, Lp-IR score, GlycA, sTfR, hs-CRP. These provide baseline and trend data but respond slowly to interventions. Annual testing is sufficient unless you have a specific reason to check more frequently. If you are on a stable protocol with no changes, annual testing of these advanced markers confirms that nothing is drifting.